Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Brand Name
Lincomycin
Generic Name
Lincomycin Hydrochloride
Active Ingredient
LincomycinCategory
Other
Salt Form
Hydrochloride
Variants
5
References used for this content
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Lincomycin, you must consult a qualified healthcare professional.
| 39822-0350 |
| 300 mg/mL | INJECTION, SOLUTION | INTRAMUSCULAR, INTRAVENOUS, SUBCONJUNCTIVAL | 39822-0353 |
| 300 mg/mL | INJECTION, SOLUTION | INTRAMUSCULAR, INTRAVENOUS, SUBCONJUNCTIVAL | 25021-193 |
Detailed information about Lincomycin
Lincomycin is a potent lincosamide antibiotic used to treat serious bacterial infections caused by susceptible Gram-positive organisms. It is typically reserved for patients allergic to penicillin or when other treatments are inappropriate.
Dosage for Lincomycin is highly individualized based on the severity of the infection and the patient's body weight. According to standard clinical protocols in 2026:
Lincomycin is approved for use in pediatric patients older than one month of age. It should not be used in neonates (infants under 4 weeks old) due to the risk of 'Gasping Syndrome' associated with the preservative benzyl alcohol often found in the injection.
In patients with severe renal impairment (kidney dysfunction), the body cannot clear Lincomycin efficiently. Healthcare providers typically reduce the dose to 25% to 30% of the standard dose for patients with a creatinine clearance of less than 10 mL/min. Frequent monitoring of serum drug levels may be required.
Since the liver is involved in the metabolism and biliary excretion of Lincomycin, patients with significant liver disease (such as cirrhosis) require careful monitoring. While specific dose reduction formulas are less standardized than for renal impairment, a lower frequency of dosing is often recommended to prevent drug accumulation and toxicity.
Older adults often have age-related declines in kidney and liver function. Dosage should be started at the lower end of the range, and healthcare providers must monitor these patients closely for the development of diarrhea, which can be more severe in this population.
In a clinical setting, a missed dose is unlikely as the medication is administered by staff. However, if you are taking Lincomycin at home and miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and resume your regular schedule. Do not double the dose to catch up.
Signs of a Lincomycin overdose may include severe nausea, vomiting, abdominal pain, and in extreme cases of rapid IV administration, low blood pressure or heart rhythm disturbances. If an overdose is suspected, contact a poison control center or seek emergency medical attention immediately. Hemodialysis and peritoneal dialysis are not highly effective at removing Lincomycin from the blood.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not stop the medication early, even if you feel better, as this can lead to the return of the infection and the development of antibiotic resistance.
The most frequently reported side effects of Lincomycin involve the gastrointestinal (GI) system. Because the drug alters the normal bacterial flora of the gut, patients commonly experience:
Lincomycin is a potent antibiotic that must be used with caution. It is not intended for minor bacterial infections or viral infections like the common cold or flu. Misuse of antibiotics leads to the development of drug-resistant bacteria, which is a major global health threat in 2026. Before starting Lincomycin, ensure your doctor knows your full medical history, especially any history of gastrointestinal disease.
Full Text Summary: Lincomycin carries a Boxed Warning regarding Clostridioides difficile-associated diarrhea (CDAD). Treatment with Lincomycin alters the normal flora of the colon and may permit overgrowth of C. difficile. This bacterium produces toxins (Toxin A and B) that contribute to the development of CDAD. CDAD must be considered in all patients who present with diarrhea following antibiotic use. If CDAD is suspected or confirmed, ongoing antibiotic use not directed against C. difficile may need to be discontinued, and appropriate fluid/electrolyte management and protein supplementation should be initiated.
Lincomycin must NEVER be used in the following circumstances:
Lincomycin is classified as FDA Pregnancy Category C. This means that animal reproduction studies have shown an adverse effect on the fetus, or there are no adequate and well-controlled studies in humans. Lincomycin does cross the placental barrier and can be found in fetal circulation. While there is no definitive evidence of teratogenicity (causing birth defects) in humans, it should only be used during pregnancy if the potential benefit clearly outweighs the potential risk to the fetus. It is generally avoided in the first trimester unless no other options exist.
Lincomycin is excreted in human breast milk in low concentrations. While it is generally considered compatible with breastfeeding by some authorities, there is a risk that the drug could alter the infant's gut microbiome, leading to diarrhea or sensitization (developing an allergy). Nursing mothers should monitor their infants for any signs of GI distress or thrush (yeast infection). In some cases, a healthcare provider may recommend temporary discontinuation of breastfeeding or choosing an alternative antibiotic.
As noted previously, Lincomycin is contraindicated in infants under one month of age due to the risk of benzyl alcohol toxicity. In older children, Lincomycin is effective for serious infections, but pediatricians must calculate the dose strictly based on body weight (mg/kg). There is no evidence that Lincomycin affects bone growth, unlike tetracyclines, making it a viable option for bone infections in children.
Lincomycin is a lincosamide antibiotic that targets the bacterial ribosome. Specifically, it binds to the 23S RNA of the 50S ribosomal subunit. This binding site overlaps with those of macrolides and streptogramins. By binding here, Lincomycin inhibits the initiation of peptide chain synthesis and prevents the translocation (movement) of the ribosome along the mRNA strand. This effectively halts the production of proteins necessary for bacterial survival and replication. Its action is primarily bacteriostatic, but it can be bactericidal against certain strains of Streptococcus.
The efficacy of Lincomycin is primarily linked to the 'Time above MIC' (T > MIC). This means the clinical outcome is best when the concentration of the drug in the blood or tissue remains above the Minimum Inhibitory Concentration (the lowest concentration needed to stop bacterial growth) for a significant portion of the dosing interval. There is a clear dose-response relationship up to a certain threshold, after which increasing the dose only increases toxicity without improving the cure rate.
| Parameter | Value |
Common questions about Lincomycin
Lincomycin is a specialized antibiotic used to treat serious bacterial infections caused by Gram-positive organisms like Staphylococcus and Streptococcus. It is most commonly prescribed for severe skin infections, pneumonia, and bone infections (osteomyelitis) when other antibiotics like penicillin cannot be used due to allergies. Because of its risk for causing severe diarrhea, it is generally reserved for serious cases rather than minor illnesses. It works by stopping bacteria from producing the proteins they need to grow. Always take the full course as prescribed by your healthcare provider.
The most common side effects of Lincomycin are gastrointestinal, including nausea, vomiting, and diarrhea. Some patients may also experience abdominal pain or inflammation of the mouth and tongue. If administered by injection, pain or swelling at the injection site is frequently reported. While many of these effects are mild, diarrhea can sometimes become severe and life-threatening. You should contact your doctor if you experience watery or bloody stools. Other less common effects include dizziness and ringing in the ears.
There is no known direct chemical interaction between Lincomycin and alcohol that would cause a dangerous reaction. However, healthcare providers generally recommend avoiding alcohol while treating a serious infection. Alcohol can weaken your immune system and irritate your digestive tract, which might worsen the stomach-related side effects of the antibiotic. Staying hydrated with water is much more beneficial for recovery. If you do choose to drink, keep it to a minimum and monitor for increased dizziness.
Lincomycin is classified as FDA Pregnancy Category C, meaning its safety in human pregnancy has not been fully established. Animal studies have suggested potential risks, and the drug is known to cross the placenta to reach the baby. It should only be used if the infection is serious and there are no safer alternatives available. Your doctor will perform a risk-benefit analysis to determine if it is necessary for your health. Always inform your healthcare provider if you are pregnant or planning to become pregnant before starting this medication.
When given by injection, Lincomycin begins working against the bacteria almost immediately, reaching peak levels in the blood within an hour. However, you may not feel a significant improvement in your symptoms for 24 to 48 hours. It takes time for the antibiotic to reduce the bacterial load enough for inflammation and fever to subside. Even if you feel better quickly, it is vital to complete the entire course of treatment. Stopping early can lead to the infection returning or the bacteria becoming resistant to the drug.
You should not stop taking Lincomycin suddenly without consulting your doctor, as this can allow the infection to return. However, there is one major exception: if you develop severe, watery, or bloody diarrhea, you should stop the medication and call your healthcare provider immediately. This could be a sign of a dangerous colon infection called *C. diff*. For any other side effects, talk to your doctor before making changes. Completing the full prescribed course is essential for ensuring the bacteria are completely eradicated.
If you miss a dose of Lincomycin, take it as soon as you remember. If it is nearly time for your next scheduled dose, skip the missed dose and continue with your regular timing. Do not take two doses at once to make up for the one you missed, as this can increase the risk of side effects. If you are receiving the medication in a hospital or clinic, the staff will manage the schedule for you. If you miss multiple doses, notify your doctor to ensure the treatment remains effective.
There is no clinical evidence to suggest that Lincomycin causes weight gain. In fact, because the most common side effects are nausea, vomiting, and diarrhea, some patients might experience temporary weight loss during treatment. If you notice significant swelling or rapid weight gain (fluid retention), this could be a sign of a kidney problem or an allergic reaction and should be reported to your doctor immediately. Long-term changes in weight are not associated with this short-term antibiotic therapy.
Lincomycin can interact with several other medications, so a full review by your pharmacist is necessary. It should not be taken with erythromycin, as they block each other's effectiveness. It can also dangerously increase the effects of muscle relaxants used during surgery. If you are taking blood thinners like Warfarin, your blood levels may need to be checked more often. Always provide your doctor with a complete list of all prescriptions, over-the-counter drugs, and herbal supplements you are currently using.
Yes, Lincomycin is available as a generic medication, specifically as Lincomycin Hydrochloride. Generic versions are required by the FDA to have the same quality, strength, and purity as the original brand-name drug (Lincocin). Using the generic version can be a cost-effective way to treat serious infections. Availability may vary depending on your region and whether you require the injectable or oral form. Your healthcare provider or pharmacist can help you determine the most affordable and appropriate option for your treatment.
Other drugs with the same active ingredient (Lincomycin)
> Warning: Stop taking Lincomycin and call your doctor immediately if you experience any of the following serious symptoms:
Prolonged use of Lincomycin can lead to 'superinfections.' This occurs when the antibiotic kills off susceptible bacteria, allowing resistant organisms—such as fungi (yeast) or resistant bacteria like Pseudomonas—to overgrow. Long-term use also increases the cumulative risk of bone marrow suppression, although this remains rare.
Lincomycin, like many other potent antibiotics, can cause a condition called pseudomembranous colitis, ranging in severity from mild diarrhea to fatal colitis (inflammation of the colon). This is caused by the overgrowth of the bacterium Clostridioides difficile (C. diff). Because this condition can be life-threatening, Lincomycin should only be used for serious infections where less toxic antimicrobial agents are inappropriate. Patients must be monitored for diarrhea for several weeks following the conclusion of therapy.
Report any unusual symptoms to your healthcare provider immediately. Early detection of side effects is key to preventing long-term complications.
Patients receiving Lincomycin for more than a few days typically require the following tests:
While Lincomycin does not typically cause drowsiness, side effects like dizziness or tinnitus (ringing in the ears) can occur. Patients should determine how they react to the medication before driving or operating heavy machinery.
There is no direct chemical interaction between Lincomycin and alcohol. However, alcohol can irritate the gastrointestinal tract and dehydrate the body, which may worsen the GI side effects of Lincomycin or delay recovery from the underlying infection. It is generally advised to avoid alcohol while fighting a serious infection.
Do not stop taking Lincomycin abruptly unless directed by a doctor due to a serious side effect. Stopping an antibiotic early can allow the remaining bacteria to multiply, leading to a relapse of the infection that may be harder to treat. There is no 'withdrawal syndrome' associated with Lincomycin, but the clinical risk is the failure of infection resolution.
> Important: Discuss all your medical conditions with your healthcare provider before starting Lincomycin, especially if you have asthma, liver disease, or kidney disease.
Lincomycin may interfere with certain laboratory tests:
For each major interaction, the management strategy involves either avoiding the combination, adjusting the timing of doses, or increasing clinical monitoring of the patient's symptoms and lab values.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including over-the-counter drugs.
Conditions requiring a careful risk-benefit analysis by a healthcare provider include:
There is a high degree of cross-sensitivity between Lincomycin and Clindamycin. If you are allergic to one, you are almost certainly allergic to the other. There is no known cross-sensitivity between Lincomycin and penicillins, which is why Lincomycin is often used as an alternative for penicillin-allergic patients.
> Important: Your healthcare provider will evaluate your complete medical history, including any previous reactions to antibiotics, before prescribing Lincomycin.
Clinical studies have shown that older adults (over 65) are at a significantly higher risk of developing severe diarrhea and pseudomembranous colitis when taking Lincomycin. Furthermore, age-related declines in renal (kidney) function mean the drug stays in the body longer. Healthcare providers typically use lower doses and monitor bowel frequency very closely in this population. Dehydration from diarrhea can also be more dangerous in the elderly, requiring rapid intervention.
In patients with a GFR (Glomerular Filtration Rate) below 30 mL/min, Lincomycin clearance is significantly reduced. For those with end-stage renal disease (ESRD), the half-life can extend to 10-15 hours. Dosing intervals are usually widened (e.g., giving the drug every 24 hours instead of every 8-12). Lincomycin is not significantly removed by hemodialysis or peritoneal dialysis, so 'top-up' doses after dialysis are not required.
Because the liver is a primary site for Lincomycin metabolism and its subsequent excretion into bile, patients with Child-Pugh Class B or C hepatic impairment require careful monitoring. Accumulation of the drug can lead to increased side effects, particularly hematologic (blood-related) toxicity. Dose reductions are often necessary.
> Important: Special populations require individualized medical assessment and frequent follow-up with a healthcare provider.
| Bioavailability | 20-30% (Oral); 100% (IM/IV) |
| Protein Binding | 70% to 75% |
| Half-life | 4 to 6 hours (Normal function) |
| Tmax | 30-60 minutes (IM); Immediate (IV) |
| Metabolism | Hepatic (Partial) |
| Excretion | Renal (10-15%); Biliary/Fecal (Remainder) |
Lincomycin is the parent compound of the lincosamide class. The only other major drug in this class currently used in human medicine is Clindamycin (a 7-chloro-7-deoxy derivative of lincomycin). These drugs are chemically distinct from macrolides but share a similar mechanism of action and spectrum of activity.